Calls for aggressive control of semaglutide supply amid ongoing global shortage
The TGA needs to do more to address the 'unique and worrying' situation, experts say
Leading doctors have urged health authorities to aggressively control supply of semaglutide, including a potential emergency stockpile, as the global shortage of the drug drags on.
This week, AMA president Professor Steve Robson said reserves of the GLP-1 receptor agonist should be set aside for patients with type 2 diabetes in a bid to thwart off-label prescribing for weight loss.